About 91% of low-grade abnormalities on Pap smears in immunocompetent young women regress within 3 years of their finding, and only about 3% progress to high-grade disease, according to a recent cohort study. The findings provide strong support for the position that subjecting all young women with low-grade squamous intraepithelial lesions (LSIL) to colposcopy is unwarranted.
About 91% of low-grade abnormalities on Pap smears in immunocompetent young women regress within 3 years of their finding, and only about 3% progress to high-grade disease, according to a recent cohort study. The findings provide strong support for the position that subjecting all young women with low-grade squamous intraepithelial lesions (LSIL) to colposcopy is unwarranted.
The longitudinal study of human papillomavirus (HPV) infection included females between 13 and 22 years of age. The researchers found that of 187 women with LSIL, 61% regressed by 12 months and 91% regressed by 36 months. They found no associations between regression and HPV status at baseline, sexual behavior, contraceptive use, substance or cigarette use, incident sexually transmitted infection, or biopsy.
While the study was not designed to examine factors that would predict regression, a negative HPV test at a subsequent visit was a good indicator that LSIL regressed. HPV status at the current visit was associated with rate of regression, whether infection was caused by one or more viral types (relative hazard=0.3 and 0.14, respectively). Multiple HPV types had the strongest association with LSIL persistence, a finding that the researchers felt deserved further investigation.
The author of an accompanying editorial agreed, writing that the purpose of screening is to prevent cervical cancer by detecting lesions that will probably become cancerous, and that the psychosexual damage associated with colposcopy in young women outweighs any provided benefit.
Moscicki AB, Shiboski S, Hills NK, et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet. 2004;364:1678-1683.
Szarewski A, Sasieni P. Cervical screening in adolescents-at least do no harm. Lancet. 2004;364:1642-1643.
Link between prenatal air pollution and reduced lung function in offspring reported
July 25th 2024Higher prenatal exposure to PM2.5 pollution is associated with reduced lung volume and airflow limitation in children, highlighting the critical impact of air pollution on in utero lung development.
Read More
Cut costs observed from out-of-home care in children with prenatal substance exposure
July 24th 2024A recent study reveals that while children exposed to maternal substance use face higher hospital costs up to age 20 years, out-of-home care significantly mitigates this financial burden.
Read More
Global progress in neonatal tetanus elimination from 2000 to 2022
July 18th 2024Incorporating maternal and neonatal tetanus elimination strategies into national immunization activities is crucial for sustaining elimination and reducing neonatal mortality worldwide, as highlighted by the latest CDC report.
Read More
PreTRM test shows efficacy in reducing severe neonatal morbidity and mortality
July 18th 2024The PreTRM test, a blood-based biomarker test for predicting preterm birth risk, has demonstrated significant efficacy in lowering severe neonatal morbidity and mortality, as reported by Sera Prognostics Inc.
Read More